首页 | 本学科首页   官方微博 | 高级检索  
     

二术二陈汤加减对脾虚痰湿证多囊卵巢综合征患者的调理作用
引用本文:李雪娇,赵锐,陈惠丽,李丽红,吴敏. 二术二陈汤加减对脾虚痰湿证多囊卵巢综合征患者的调理作用[J]. 中国实验方剂学杂志, 2021, 27(8): 101-106
作者姓名:李雪娇  赵锐  陈惠丽  李丽红  吴敏
作者单位:海南省妇女儿童医学中心;华中科技大学同济医学院附属协和医院
基金项目:海南省医药卫生科研项目(1601320313A2001)。
摘    要:
目的:观察二术二陈汤加减对脾虚痰湿证多囊卵巢综合征(PCOS)代谢的调节效果,以及对脂肪细胞因子的影响.方法:将140例患者按随机数字表法分为对照组和观察组各70例.两组均口服盐酸二甲双胍片,500 mg/次,3次/d.对照组口服越鞠二陈丸,0.5 g/次,3次/d;观察组内服二术二陈汤加减,l剂/d;两组疗程均为24...

关 键 词:多囊卵巢综合征  脾虚痰湿证  二术二陈汤  代谢异常  脂肪细胞因子
收稿时间:2020-08-26

Regulatory Effect of Modified Erzhu Erchentang on Patients with Polycystic Ovary Syndrome and Spleen Deficiency and Phlegm Dampness
LI Xue-jiao,ZHAO Rui,CHEN Hui-li,LI Li-hong,WU Min. Regulatory Effect of Modified Erzhu Erchentang on Patients with Polycystic Ovary Syndrome and Spleen Deficiency and Phlegm Dampness[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2021, 27(8): 101-106
Authors:LI Xue-jiao  ZHAO Rui  CHEN Hui-li  LI Li-hong  WU Min
Affiliation:(Hainan Women and Children's Medical Center,Haikou 570206,China;Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology,Wuhan 430011,China)
Abstract:
Objective: To observe the regulatory effect of modified Erzhu Erchentang on metabolization of polycystic ovary syndrome(PCOS)with spleen deficiency and phlegm dampness syndrome.Method: Patients 140 cases were divided into control group and observation group. Both groups were given metformin hydrochloride tablets,500 mg/time,3 times/day. Control group was given Yuejun Erchen pills,0.5 g/time,3 times/day,while observation group was given modified Erzhu Erchentang,1 dose/day. The course of treatment lasted for 24 weeks. Before and after treatment,levels of fasting blood glucose(FBG),fasting insulin(FINS),glycosylated hemoglobin Alc(HbA1c),2-hour postprandial blood glucose(2 h PG),blood lipid,waist circumference(WC),body mass index(BMI),waist hip ratio(WHR),luteinizing hormone(LH),follicle stimulating hormone(FSH),serum testosterone(T),estradiol(E2),dehydroepiandrosterone sulfate(DHEAS),sex hormone binding globulin(SHBG),leptin(LP),adiponectin(APN),resistin,visfatin and tumor necrosis factor-α (TNF-α) were detected. Homeostasis model assessment insulin resistance(HOMA-IR)was calculated,modified Erzhu Erchentang was scored,and recovery of menstruation and ovulation and ovarian volume were recorded. Result: Levels of FBG,2 h PG,HbA1c,FINS,HOMA-IR,triglyceride(TG),total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),LH,FSH,T,E2,DHEAS, LP, resistin, visfatin and TNF-α in observation group were lower than those in control group(P<0.01),and levels of BMI,WC and WHR were lower than those of control group(P<0.05). And levels of high-density lipoprotein cholesterol(HDL-C), SHBG and APN were higher than those in control group(P<0.01). Score of modified Erzhu Erchentang was lower than that in control group(P<0.01),and ovarian volume was smaller than that in control group(P<0.01). The normal rate of BMI was 49.23%(32/65),which was higher than 30.30%(20/66)in control group(χ2=5.151,P<0.05). The normal rate of blood lipid was 93.85%(61/65),which was higher than 81.82 %(54/66)in control group(χ2=4.418,P<0.05). The normal rate of blood glucose was 96.92%(63/65),which was higher than 86.36%(57/66)in control group(χ2=4.474,P<0.05). Conclusion: In addition to adipocytokines,modified Erzhu Erchentang could regulate adipokines of patients of PCOS with spleen deficiency and phlegm dampness, improve glucose, lipid metabolism and overweight,adjust endocrine hormone,reduce clinical symptoms and improve ovarian structure,so as to create conditions for conception.
Keywords:polycystic ovary syndrome  spleen deficiency and phlegm dampness syndrome  Erzhu Erchentang  metabolic abnormality  adipocyte factor
本文献已被 维普 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号